When combined with multidrug chemotherapy, radiation, anti-GD2, and anti-CTLA-4, this anti-CD40 and CpG therapy exhibited potent anti-tumor effects in mice with 9464D neuroblastoma tumors, repolarizing TAMs towards an M1 phenotype [161]. Here, CD40 is linked to neuroblastoma.